| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $155.00K | $146.00K | $152.00K | $212.00K | $101.00K |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $420.00K | $383.00K | $395.00K | $374.00K | $437.00K |
| R&D | – | – | – | – | – |
| SG&A | $364.00K | $335.00K | $338.00K | $317.00K | $360.00K |
| Operating Income | -$265.00K | -$237.00K | -$243.00K | -$162.00K | -$336.00K |
| Interest Expense | – | – | – | – | $5.00K |
| Tax Expense | – | – | – | $0.00 | $0.00 |
| Net Income | -$46.00K | -$18.00K | -$21.00K | $181.00K | $70.00K |
| EPS (basic) | -0.0100 | -0.0100 | -0.0100 | 0.0400 | 0.0100 |
| EPS (diluted) | -0.0100 | -0.0100 | -0.0100 | 0.0400 | 0.0100 |
| Shares (diluted) | $5.13K | $5.13K | $5.13K | $5.13K | $5.13K |